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Abstract
Vectors based on c-retroviruses or lentiviruses have been shown to stably express therapeutical transgenes and effectively
cure different hematological diseases. Molecular follow up of the insertional repertoire of gene corrected cells in patients
and preclinical animal models revealed different integration preferences in the host genome including clusters of
integrations in small genomic areas (CIS; common integrations sites). In the majority, these CIS were found in or near genes,
with the potential to influence the clonal fate of the affected cell. To determine whether the observed degree of clustering
is statistically compatible with an assumed standard model of spatial distribution of integrants, we have developed various
methods and computer programs for c-retroviral and lentiviral integration site distribution. In particular, we have devised
and implemented mathematical and statistical approaches for comparing two experimental samples with different numbers
of integration sites with respect to the propensity to form CIS as well as for the analysis of coincidences of integration sites
obtained from different blood compartments. The programs and statistical tools described here are available as workspaces
in R code and allow the fast detection of excessive clustering of integration sites from any retrovirally transduced sample
and thus contribute to the assessment of potential treatment-related risks in preclinical and clinical retroviral gene therapy
studies.
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Introduction
Various clinical gene therapy trials have been carried out
demonstrating a clear benefit for many of the treated patients
[1,2,3,4,5]. In preclinical studies and in some of the clinical trials
using viral vectors, various side-effects due to vector integration in
the genome have been observed, ranging from immortalization [6]
to clonal dominance [4,7,8,9] and even oncogenesis [10,11,12,13,
14,15,16,17,18]. Integration site (IS) analysis via linear amplifica-
tion-mediated PCR and high-throughput sequencing [19,20,21]
has proven to be a highly efficient technology for uncovering IS
distribution in a large scale and for integration induced effects on
the surrounding genomic DNA regions. Of particular interest is
the formation of clusters of integrations, termed common
integration sites (CIS), as an indicator for clone selection
[22,23,24]. To evaluate if the observed clustering may have
occurred by chance it is necessary to compare the experimental
results with those to be expected under an assumed model
distribution. Because it is known that c-retroviruses show a
different IS pattern than lentiviruses [25,26] we developed specific
tools for these IS distributions.
Here, we describe methods and computer programs for the
statistical analysis of the number of CIS as well as the number of IS
involved in CIS. All computer programs referred to in the sequel
were written in R code (cran.r-project.org). Technical details are
provided in the Supporting Documents.
Methods
Definitions, abbreviations and conventions
The following terminology will be used: A CIS of order n is
defined asann-tuple ofISsuch that themaximumdistancebetween
the elements is no greater than a fixed bound dn, the window size
used for defining the CIS. While in our examples with relatively
small sample sizes we chose the window sizes for CIS definition
(d2=30 kb, d3=50 kb, d4=100 kb, and dn=200 kb, for n.4) to
be identical to those used in earlier investigations [22,24], our
methods and programs allow for an arbitrary choice of dn, a feature
that may be useful with increasing sample sizes after high
throughput sequencing. As for alternative definitions of CIS
proposed in the literature [27,28], the last section of this paper
will briefly analyze how our approachrelates to these developments.
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is number of observed IS in the part of the genome under
study
cisn number of CIS of order n
iscisn number of IS involved in CIS of order n
E(X) expected value of the random variable X
g length of the genome or the part of the genome under
study
TSS transcriptional start sites
nTSS number of TSS in the particular part of the genome
under study
ITSS interval(s) around a TSS possibly affected by
preferential insertion of c-retroviral vectors (the interval is assumed
to be symmetric around the TSS)
w halfwidth of the interval(s) ITSS
pTSS proportion of IS allocated to the ITSS
ppref proportion of the TSS affected by the preference
G,H gene coding region and its complement (resp.) in the
particular part of the genome under study
qG,qH proportion of IS assumed to insert into gene
coding regions and the complement (resp).
General aspects
This paper is concerned primarily with the number of CIS (or IS
involved in CIS) of a given order n. Generally, the analysis is based
on an assumed spatial distribution, fIS, of the IS. In statistical
terms, this represents a null hypothesis. Expected values of cisn or
iscisn under H0 are calculated, and the observed numbers are
compared with their statistical distribution fcis,n and fiscis,n (resp.)
under H0, yielding p-values.
Two approaches were adopted (the first one applicable
only to the number of CIS):
(1) Mathematical formulae for the expected value along with
assumptions regarding the distributional form of fcis,n.W e
assumed a Poisson distribution, which is an approximation to
(and a limiting distribution of) the binomial in case of rare
events. Thus, the Poisson distribution does not concern the IS
but the number of CIS of order n. The approximation may be
used if the probability of a random IS to be part of a CIS is
small (,5%).
(2) A more general and comprehensive approach relying on
computer simulations of fIS. In contrast to approach (1) this
allows to take into account the spatial structure of the genes or
the TSS. With computer simulations, no parametric model
(like the Poisson distribution) for the distribution of the CIS is
required.
Some explanations are in order to understand the scope of the
analyses. If a fixed distribution fIS is assumed then the analysis will
merely yield a conclusion about whether or not the observed
number of CIS of order n, cisn, is compatible with this assumption
(compatibility being measured by the p-value). A small p-value is
indicative that the degree of clustering is stronger than implied by
the model.
As an alternative, a family of IS distributions may be assumed,
the members of which differ in the values of one or more
parameters. Thus, e.g, retroviral distributions with preference for
the neighborhood of TSS may differ in the assumed width of this
neighborhood and in the degree of the preference. Then two types
of questions may be asked: (i) whether cisn is compatible with
certain given values of the parameter(s); and (ii) how the
parameter(s) must be chosen so as to be statistically compatible
with the observed number cisn, or even so that the expected
number of CIS is equal to cisn.
Finally, in some of the methods developed for comparing the
number of CIS observed in two studies with different numbers of
IS, the distributional assumption for the IS is not directly used for
calculating expected values, but is rather treated as a nuisance
parameter which determines the (necessary) adjustment of the
results of the comparison.
As for p-values, in many of our computer programs the user can
select the direction of the statistical tests, namely, one-sided (upper
tail or lower tail) or two-sided testing. Whenever H0 stipulates a
uniformdistribution, however, onlyone-sided testing is appropriate.
Whenever a p-value, psim, is based on computer simulations, it is
only an estimate of the true p-value p (which is a probability). If,
e.g., the test statistic is given by the number of observed CIS of
order n, the (one-sided) psim is defined by the ratio of the number
of simulation runs resulting in at least cisn (i.e., the number
observed in the experimental sample) CIS of order n, to the total
number of simulation runs, nsim. As pointed out by Li et al. [29],
it then is advisable to calculate upper confidence bounds for p,
based on psim. This is easy to accomplish, given that psim follows a
binomial distribution B(nsim,p). In our programs, whenever
analyses are based on simulations, exact one-sided, test-based
95% upper confidence bounds (Clopper-Pearson bounds) for the
true p-values regarding the overall (i.e., not the chromosome-
specific) results are calculated.
Another aspect is the multiplicity of tests. Most analyses
generate more than one p-value, due to the fact that different
orders of CIS are analyzed and/or different distributional
assumptions (corresponding to different null hypotheses) are made.
Hence, in some situations issues of multiple testing arise. There are
numerous methodological strategies for dealing with multiple
testing, see, e.g., Hsu [30] for a survey of the issues and
approaches. The methods and programs described here leave
the choice of how to adjust for multiplicity to the user, and,
therefore, these questions will not be addressed further in this
manuscript. The reader is strongly advised to formulate the testing
strategies, and thus the use and interpretation of the p-values, prior
to the data analysis.
Results
Modeling a uniform distribution of the IS
While it is known that c-retroviruses do not show a uniform
integration pattern, analyses of this type may be of interest when it
comes to lentiviruses, see below.
In Abel et al. [31] a mathematical framework was derived for
the calculation of expected values E(cisn) of CIS of order n
(n=2,3,4) under the null hypothesis that the IS are uniformly
distributed. In principle, it is possible to derive formulae for orders
n.4 using the recursive approach given in Abel et al. [31]. The k-
th order requires a formula for
P dk{1
d~1
dk{2, which can be obtained
following the line set out in Heuser [32], page 130.
The resulting formula for CIS of order n=5 is given in the
Supporting Document Text S1.
The formulae were implemented in elementary programs cis
and cisv yielding expected values and p-values based on a Poisson
distribution of the number cisi of order i (i#5). Note that in most
practical applications E5%1 so that, assuming a Poisson
distribution for cisn, the p-value of a single observed CIS of order
5, is<En and thus%1, as well. Since En,En21, the observation of
at least one CIS of order n implies a p-value of p,E5%1, an upper
Viral Integration Site Analysis
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n.5, is rarely needed.
Generally, the approximations involved in the formulae are
excellent. However, while the formula-based approach allows a
very quick, rough orientation, in many situations computer
simulations will be more satisfactory. First, the formulae may be
dubious if g is not considerable larger than the window size dn.
Second, no formulae have been derived for orders .5. And third,
no formulae are available for the number of IS involved in
overlapping CIS. It is only when the CIS of order n can be
assumed to be extremely sparse, so that overlaps can be neglected,
that this number is approximately equal to cisn*n.
Modeling a more general c-retroviral distribution of the
IS
The term c-retroviral distribution will be used to designate a
distribution of the insertions which assumes that insertions occur
preferentially in the vicinity of the TSS, but are uniformly
distributed in the remainder of the genome [26]. A distribution of
this type was used in the analyses carried out by Wu et al [33].
Mathematically, the c-retroviral distribution is a parametric
class of distributions, the parameters being
N the halfwidth w of the intervals ITSS
N the proportion pTSS
N the proportion ppref.
(see above). As is easy to see, the uniform distribution is a special
case of this class.
To obtain mathematical formulae, it must be assumed that the
preferential allocation of IS expressed by pTSS and ppref is
independent on the particular location of the TSS.
In Abel et al. [31] general formulae were derived for calculating
the expected number of CIS of order 2, given the values of the
parameters mentioned above, and solutions of these equations for
the case w=5 kb were presented. In the Supporting Document
Text S2 the solutions are given in a more general form allowing
for arbitrary w, and including a slight correction. It is important to
note that, as long as w,d2/2, the expected values do not depend
on the spatial distribution of the IS inside of the ITSS, as proven in
the Supporting Document Text S2.
Again, this approach (made available in the program cisretro)i s
useful for a quick approximate analysis using hypothetical values
for the parameters, in particular ppref. Note that pTSS can be
estimated from IS and TSS data (as the proportion of IS lying in
the union of the ITSS), and whenever an estimate is available it
may be used in place of a hypothetical value.
Example 1. For the human genome, Wu et al. [33], using
computer simulations based on is=1,200, pTSS=25%, ppref=5%,
w=5 (kb), obtained E(cis2)<55. A recalculation by means of the
mathematical formulae described above (with nTSS=20,484,
g=312,000,000 kb) yielded E(cis2)=56.1.
However, the assumption underlying the formulae, namely that
CIS arising from IS located in two different (e.g. overlapping) ITSS
are negligible, may be problematic. As can be easily calculated,
this approximation is, indeed, justified (with w=5 kb) if the TSS
can be assumed to be uniformly distributed. In reality, however,
the distribution of the TSS in the genome is far from uniform, but
rather shows a marked clustering, which then, by virtue of the
preferential allocation of IS, may increase the expected number of
CIS beyond the values implied by the formulas if a high
percentage of IS are located in the ITSS.
This observation is highlighted by the positions of the first 15
TSS on chromosome 1:
14362, 34611, 69090, 367658, 621097, 761586, 763063,
803452, 852952, 861120,879583, 895966, 901876,
910578, 934341
Whilethese 15 TSS have a spanof almost 1,000 kb, no less than 10 of
them lie in an interval of 250 kb (between position 750 and 1,000 kb),
and in several cases the ITSS with w=5 kb will even overlap.
In other words, in order to perform a well-founded analysis for
c-retroviral insertions, computer simulations are needed that take
into account the exact positions of the TSS (see below).
Modeling a lentiviral distribution of the IS
Lentiviruses are known to insert preferentially into the gene
coding regions [25]. Conditional on this preponderance their IS
are thought to be uniformly distributed both in the gene coding
regions G and their complement H.
If this assumption holds true, then statistical analyses - not
taking into account the exact position and length of every single
gene - can be carried out by applying the methods developed for
uniform distributions separately to the gene coding regions and
their complement.
This approach was implemented in the program cislenti. The
program yields formula-based expected values for cisn, n=2,…,5,
as well as p-values derived from Poisson distributions with these
expected values, evaluated separately for G and H, as well as for
G<H.
Again, this formula based approach is mainly meant for quick
hypothetical model-based calculations (‘‘scenarios’’).
Example 2. We consider a data set of lentiviral IS in dividing
mouse cells (SC-1 mouse fibroblasts and hematopoietic progenitor
cells), analyzed by our group [34].
The integration site analysis yielded 611 IS, forming a total of
33 CIS of order 2. Using the program lenti with the parameters
pertaining to the mouse (g=2654855048 b, length of G=
939587421 b), it was found that under the null hypothesis of a
lentiviral distribution the expected value E(cis2) ranged from 4.2
(for qG=35.4%, a value corresponding to a uniform distribution
of the IS and also obtained using the program cis) and 11.9,
attained for qG=100%. Equating qG to the sample value of 77.1%
yielded E(cis2)=7.4. Regardless of the true value of qG, the
observed value of cis2 was significantly higher (p,10
26) than the
expected value.
A caveat similar to that made for c-retroviral analysis also
applies to lentiviruses: The formula-based analysis, which treats
the gene-coding regions and their complement as connected
intervals, may be questionable if the number of IS is high so that
many CIS are formed by combinations of IS from G and H. A
more appropriate analysis, taking into account the exact structure
of the regions is provided by the programs described in the next
paragraph.
Simulation-based CIS analysis using IS location data
The basic methods and programs described above are
cornerstones for more comprehensive analyses of IS data. Given
a data set of IS locations, the analysis of CIS comprises at least the
following steps:
1. Determine the number of CIS of order 2,3….(In our programs
the maximum order analyzed was n=30.)
2. Determine the location and number of IS involved in CIS of
order 2, 3…
Viral Integration Site Analysis
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uniform distribution, the c-retroviral distribution with prefer-
ence for ITSS, or a lentiviral distribution, as described above.
I.e., these distributions are the null hypothesis H0 to which the
p-values refer.
All steps are performed both for each chromosome separately
and genome-wide. For each distribution two separate methods
(denoted by the suffix c and u, resp.) were implemented
representing a conditioning of the analysis on the observed
numbers of IS on the chromosomes and the observed values of the
model parameters, and an analysis without this conditioning,
respectively. Additional technical remarks can be found in
Supporting Document Text S3.
The unconditional versions were mainly intended to test
different hypothetical models. Therefore, the assumed model
parameters (e.g., in case of lentiviral distributions: the proportion
qG of IS inserting in gene coding regions; in case of c-retroviral
distributions: the parameters pTSS,p pref) have to be furnished as
program input. For chromosomes and those model features which
are observable (this is not the case for ppref, for which no
straightforward method of estimation is available) the uncondi-
tional version of the programs then yields p-values of the
chisquared goodness-of-fit test for the IS. E.g., in case of the
uniform distribution, it is tested whether the observed numbers of
IS on the chromosomes differ from those expected under H0
(which are proportional to the length of the chromosomes). In case
of c-retroviral and lentiviral models, additional goodness-of-fit tests
are carried out regarding the assumed values of the model
parameters pTSS and qG, respectively.
The programs providing a conditional analysis are conditional
both on the observed number of IS on the chromosomes and on
the observable model parameters (pTSS in case of c-retroviruses
and qG in case of lentiviruses).
Thus, in all, the package comprises 6 programs carrying out
steps 1 to 3: CISUNIFc, CISUNIFu, CISRETROc, CISRETROu,
CISLENTIc, CISLENTIu.
Some details may be of interest:
a) All analyses require the specification of the species under
investigation (rat, mouse, human). This determines the
number and length of the chromosomes used in the analysis.
b) The c-retroviral analysis (CISRETROc, CISRETROu) makes
use of a global matrix containing the positions of all TSS for
each chromosome (for humans, this amounts to a matrix with
about 20,000 rows). The main challenge of the analysis
consisted in producing uniform distributions in the comple-
ment of the ITSS, which can be visualized as a continuum
with about 20,000 holes of identical size, many of which
overlap.
b) For simplicity, the retroviral analysis assumes a uniform
distribution of the IS within the ITSS. As has been mentioned
above, this special choice will hardly affect the number of
CIS, given that the distribution inside of the ITSS plays a role
only for CIS arising from overlapping ITSS. Also, as before, it
is assumed that the preferential allocation of IS is indepen-
dent on the particular location of the TSS so that random
samples of the TSS can be drawn when modeling H0. The
structure of the programs CISRETROc and CISRETROu is
shown in Figure 1.
c) The analysis of lentiviruses requires the exact positions of all
genes on the chromosomes (stored as a global matrix in the R
workspace).
d) No separate counting of CIS is done for the union of the ITSS
in case of c-retroviruses and for gene-coding regions or their
complement in case of lentiviruses, because, as mentioned
above, these regions are highly disconnected and composed
of subintervals many of which are smaller than the defining
window sizes for CIS.
Example 3: c-retroviral vectors. As mentioned above,
because of the overlap of the ITSS (as is the case on human
chromosome 1) the formula-based approach may be unsatisfactory
when dealing with a large number of IS which are heavily
concentrated in the ITSS. To support this claim we consider an
example of 319 IS on chromosome 1 (a value found in one of our
studies), and assume the extreme case that pTSS=1.Ifp pref=1 the
mean value of CIS of order 2 obtained in 10,000 simulation runs
taking into account the length of the first chromosome
(249,250,621 bp) and the exact location of the 2,135 TSS on
this chromosome, was 50.4, compared to a formula-based
expected value of 23.7.
Example 4: Lentiviral vectors. We applied the program
CISLENTIc to the data set described in Example 2. The mean value
of cis2 obtained in 10,000 simulation runs was 6.75, with an
empirical p-value of 0, yielding an upper 95% confidence bound
for the true p-value of 0.0003. That the simulations result in a
slightly lower expected value than the formula may be due to the
fact that the formula treats the gene-coding regions as a connected
interval when in reality they are highly disconnected. We also used
the program CISLENTIu, in which the number of IS allocated to
gene coding regions of each chromosome are proportional to the
length of these regions (and not, as in CISLENTIc, to the number
actually observed). We alternatively set qG=77.1% (=the
observed value) or qG=75%, the latter value being equally
statistically compatible with the observed proportion of IS in gene-
coding regions, as judged by a non significant result of the
goodness-of-fit test for the model. This yielded even lower mean
Figure 1. Structure of CISRETROc, CISRETROu. The programs
CISRETROc and CISRETROu give the expected numbers and p-values of
CIS and IS involved in CIS based on a c-retroviral IS distribution using
Monte-Carlo methods. 7 subprograms work together to produce the
results. fp: calculates p-values based on the simulated distribution of
results; fvis: generates uniformly distributed IS locations; ftssc, ftssu:
generate randomly distributed IS in the ITSS; feval: carries out the
statistical analysis; compress: compresses highly disconnected genomic
regions produced when discarding the ITSS; ciscount: counts the CIS;
Subsim_c, Subsim_u: carry out the simulations and count the CIS for
each simulation run.
doi:10.1371/journal.pone.0024247.g001
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Comparing results from two vector integration studies
In many experiments it is necessary to compare the results
(locations of vector integrations) from two vector integration
studies e.g. when the IS profile of two different vectors used in
clinical trials have to be determined. One aspect of interest is the
inherent propensity of the IS of these vectors to form CIS. Often
the patient material that can be used for integration site analysis is
limited so that it is not possible to get a comparable amount of
DNA. Usually this implies that the numbers is1,i s 2 of observed IS
in the two samples will be different. The challenge with such an
unbalanced comparison is that the number of IS itself affects the
expected number of CIS. Even with random uniform allocation
this dependency is strong. Thus the challenge arises how to
eliminate the influence of the sample sizes of the IS on the
comparison of the CIS.
We have taken two different approaches to this challenge. The
first applies to the number of CIS only. It has a firmer theoretical
foundation but depends explicitly on some assumptions regarding
the distribution of the IS. The methods exploits the general fact
that if X1 and X2 have Poisson distributions with parameters (i.e.,
expected values) l1 and l2, respectively, then the difference X1–
X2 follows a Skellam distribution with parameters l1,l2. (The
Skellam distribution is available as a CRAN package in R.) In the
applications the true expected values l1,l2. are unknown.
However, they can be calculated (either from a formula or from
simulations) if a particular model for the distribution of the IS is
assumed.
For the c-retroviral model proposed by Wu et al. [33] one can
use the formulae given in the Supporting Document Text S2 for
calculating expected values. Thus, we have a parametric model
with the structural parameters pTSS and ppref. As mentioned
before, this approach can be considered approximately valid if the
values of pTSS and ppref are not too extreme. Here, it is assumed
that 0.1#pTSS#0.5 and 0.1#ppref#1. For each pair of structural
parameters, a p-value can be calculated from the Skellam
distribution. In this analysis, pTSS and ppref are nuisance
parameters. To eliminate these parameters we follow the approach
originally proposed by Barnard [35] for significance tests for 262
tables, in which the p-value is taken as the supremum of the p-
values over the admissible region for the nuisance parameters.
This method is implemented in the program compsk_retro which,
based on the observed difference of CIS of order 2 in the two
samples, calculates p-values for a two-dimensional grid of (pTSS,
ppref) with step width of 0.1 and 0.2, resp., and determines the
maximum of these p-values. Note, however, that the formula-
based method described above is limited to CIS of order 2, and it
cannot be applied for the number or proportion of IS involved in
CIS.
The second approach (programs comp1, comp2) is less limited in
scope and does not have any explicit distributional assumptions,
but is somewhat heuristic. It is based on a Monte-Carlo method
which adjusts for the differences in the number of integration sites.
The method has been implemented for the number/proportion
of IS involved in CIS (for which no Poisson distribution can be
assumed). Briefly, it proceeds as follows: Let IS1 and IS2 be the
samples of is1 and is2 integration sites, respectively, and assume
first that is1&is2. Random samples of size is2 are drawn repeatedly
(say, nsamp times) without replacement from IS1, and for each of
these samples the numbers of IS in CIS of different orders are
counted. This yields simulated distributions of these numbers, with
which the observed numbers of CIS in IS2 are then compared to
obtain empirical p-values.
If is1<is2 this method is unfeasible, however, because all random
samples will become highly similar. A variant of the method can
then be tried using nsamp random subsamples of identical size
%min(is1,i s 2) from both IS1 and IS2. Each subsample from IS1,IS2
then yields a number of IS in CIS of order n, and these resulting
values (x1,…,xnsamp), (y1,…,ynsamp) pertaining to IS1 and IS2,
respectively, can then be compared using a suitable test (we use
the Wilcoxon rank sum test). The whole procedure should be
repeated several times to obtain more reliable p-values (see below).
We emphasize that - exceptionally - drawing with replacement,
i.e. bootstrapping, is not applicable in this context. Generally, the
bootstrap is not a suitable tool for investigating questions that have
to do with the spatial clustering of data points. The reason is that
bootstrap samples will produce a distance of exactly 0, if the same
data point is drawn twice. I.e., the bootstrap sample will contain
many clusters even if the original distribution is uniform.
At first glance, since the samples of IS which are the basis for the
calculation of p-values are of identical size and only the sample
distribution is used, the comparisons involved in this method
appear to be neither affected by the differences in the sample sizes
is1 and is2, nor to depend on distributional assumptions for the IS.
However, as extensive simulation studies have shown, this is not
true. There is a dependence on various parameters conveyed by
an inflation of the type I error, which, incidentally, is generally
much higher in case of variant 2 than variant 1. This inflation is
due to the fact that drawing (without replacement) from the
samples of IS is not the same as drawing repeatedly from the
theoretical parent distribution of the IS.
The inflation of the type-I error means that for every concrete
data analysis a simulation study must to be carried out in order to
determine how the nominal a-level needs to be adjusted.
Example 5. To illustrate the application of the method and
the a-adjustment, consider two real samples of 2,289 vs 1,152 c-
retroviral IS [Deichmann et al., unpublished results]. The samples
contained 2,078 vs 161 CIS of order 2, which comprised 823 vs
236 (i.e.35.9% vs 20.5%) of the IS. The empirical p-value for IS in
CIS of order 2 produced by variant 1 (10,000 runs) was
p=0.0038, whereas variant 2 (10 pairs of samples of size is2/
2=576, 1,000 repetitions) yielded p=0.0009. The simulation
study analyzing the type-I error for this situation and assuming a
uniform distribution of the IS resulted in estimated real a levels of
10.2% and 21.0% for variant 1 and 2 (resp.). Also, it was found
that the nominal significance level would have needed to be
lowered to 2.2% and 0.39%, respectively, to result in a real type-I-
error of a=5%. Note, that the results of the comparison remained
highly significant even after the adjustment.
Coincidences of vector integration sites in different cell
types
In a recently carried out hematopoietic stem cell gene therapy of
ALD in two patients [36], the insertion sites of the lentiviral
vectors in purified lymphoid CD3
+ and CD19
+ cells were
compared, among others, to those found in CD14
+ and CD15
+
myeloid cells to determine whether multipotent early hematopoi-
etic progenitors had been transduced. If the number of observed
coincidences exceeds that to be expected by chance alone, this
would be indicative of initially transduced hematopoietic progen-
itor cells. In an extension of the analysis, a certain contamination
rate by FACS was to be accounted for.
The statistical inference (expected values E(coinc) of the number
of coincidences and p-values p for the observed number of
coincidences) is carried out under the null hypothesis H0 that, if no
Viral Integration Site Analysis
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represented by independent variables with lentiviral distributions
as described above. Two situations were considered:
a) No contamination.
b) Contaminations do occur. It is assumed that the proportion
of contaminated cells is the same for both cell types. The
analysis takes the robust (worst case) stance that every IS in
the contaminated part of the analyzed cells leads to a
coincidence.
For the mathematical formulae and some technical details see
the Supporting Document Text S4. In case of no contaminations,
the formulae and programs (coinc1, coinc2, resp.) permit the exact
calculation of E(coinc) and p, whereas, if contaminations are
present, only upper bounds can be determined.
Discussion
Given that nearly all leading gene-therapy studies use integrating
viral vectors, there is a need for mathematical and statistical tools
tailored for the analysis of viral integration sites. In this paper, we
focus onmethods and computer programs for theanalysis of common
integration sites (CIS), with applications both to c-retroviruses and
lentiviruses (which show different integration patterns).
Our methods and programs focus on the analysis of the number
of CIS. When starting the development of our analytical tools, we
decided to use the same methodological framework (see the
General Methodology section above) as had been proposed in
earlier publications on the subject, an approach which was
deemed statistically valid. Meanwhile, alternative definitions and
methodologies have been developed, which are more specifically
tailored to the challenge of detecting significant clusters of IS.
deRidder et al. [27] proposed a different definition of CIS, based
on peaks of the (smoothed) density function of the IS. Using the
results from computer simulations, the critical peak height for
defining a CIS is specified such that the multiple level of
significance a is controlled. This method of analysis, which is
primarily concerned with the general concept of clustering and
does not distinguish between the orders of the CIS, cannot be
reproduced by our programs, but may well be used in a
complementary way.
Starr et al. [28] adapted the window sizes to the number of IS in
the data set under consideration, such that the expected numbers
E of CIS (of the order n to be analyzed) under the null hypotheses
(i.e. assuming a certain distribution for the IS) is ,1. This
approach for defining and detecting CIS is within the scope of our
methods, although two steps are needed to reproduce them. Note
that our formulae or programs are flexible as regards the window
sizes for defining CIS, i.e., these sizes can be chosen at the
Table 1. Major constituents of the program package CIS.
Program Objective
1. Formula-based methods
cis, cisv expected numbers of CIS and p-values for the observed numbers of CIS, assuming a uniform distribution of the IS
cisretro ditto, c-retroviral IS distribution (CIS of order 2 only)
cislenti ditto, lentiviral IS distribution
coinc1 coincidences of IS in two cell types without contaminations
coinc2 coincidences of IS in two cell types with contaminations
compsk comparison of the numbers of CIS from two experiments with different numbers of IS (with expected numbers given)
compsk_retro ditto for c-retroviral IS distribution and unknown expected numbers (only CIS of order 2)
2. Basic modules used in Monte Carlo methods
ciscount counting of CIS in a given set of IS locations
isinciscount counting of IS involved in CIS
idsincisdet enumeration of the locations of IS involved in CIS
fvis generation of uniformly distributed IS locations
feval statistical analysis of the results of simulation studies
compress subroutine used to compress highly disconnected genomic regions produced when discarding the ITSS
ftssc, ftssu generation of randomly distributed IS in the ITSS
3. Monte-Carlo methods
cis_simul expected numbers and p-values for CIS and IS involved in CIS (expected numbers based on uniform IS distribution, p values based on
given total numbers)
CISUNIFc ditto, using given IS locations; conditional analysis
CISUNIFu ditto, using given IS locations; unconditional analysis
CISRETROc ditto, with expected numbers based on a c-retroviral IS distribution; conditional analysis
CISRETROu ditto, with expected numbers based on a c-retroviral IS distribution; unconditional analysis
CISLENTIc ditto, with expected numbers based on a lentiviral IS distribution; conditional analysis
CISLENTIu ditto, with expected numbers based on a lentiviral IS distribution; unconditional analysis
comp1, comp2 comparison of the numbers of CIS from two experiments with different numbers of IS (assuming uniform IS distribution), according to
method1 and 2, resp. (see text)
doi:10.1371/journal.pone.0024247.t001
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the null hypothesis (with the given number of IS in the data set)
can be determined either by applying the formulae, or, perhaps
more appropriately, by means of the simulation programs which
take into account the particular distribution of the genes and TSS.
This critical window size can then be applied in the programs for
detecting and analyzing CIS in the particular data set.
We have devised formula-based approaches useful for a quick
analysis, as well as simulation-based methods, which are appropri-
ate for samples showing intensive clustering in specific regions and
which take the entire exact genome localization of the TSS (in case
of c-retroviruses) or of genes (in case of lentiviruses) into account.
An overview of the program package is given in Table 1.
For each IS distribution modeled in the simulations, two
different methods of analysis were implemented: a conditional one
using observed number of IS for the specific genomic regions
addressed by the models, and an unconditional one based on
expected values for these numbers.
In the conditional analysis, the number of IS attributed to each
chromosome C (under H0) is simply equal to the observed number
of IS on C. In addition, this analysis is conditional on the model
parameters, which means that the observed proportions of IS in
ITSS (in case of CISRETROc) or in gene coding regions (in case of
CISLENTIc) on each chromosome are used in place of assumed
values. By contrast, in the unconditional analysis, expected instead of
observed numbers of IS are used. Thus, e.g., the number of IS
attributed to a chromosome C under H0 is calculated from the
total number of IS by using weights proportional to the
characteristics of C.
While the unconditional analysis is useful for trying and
assessing hypothetical models, conditioning, at least on the model
parameters, is preferable in the analysis of real data, where
estimations of these parameters are available. As for chromosomes,
the considerations are different, because (in contrast to the
parameters pTSS or qG) the proportions of IS on each chromosome
are not among the parameters of the mathematical models. An
analysis without conditioning on the chromosome essentially treats
the chromosomes as undistinguishable, except for characteristics
specified in the IS distribution under H0, e.g. the locations of gene
coding regions or TSS. By contrast, conditioning on the
chromosomes is appropriate if there is evidence (either biological
or statistical one) that further factors exist - of little or no interest,
but differing across the chromosomes - affecting the number of IS
and thus (indirectly) the expected number of CIS. In the
conditional analysis, these chromosome-specific influences on the
number of CIS are corrected for by taking them into account
under H0, i.e., in the simulated distribution of the IS.
Summarizing, the unconditional and conditional approaches
differ in their assumptions, methods of analysis, and results (see
Example 4). The points raised above may be helpful in deciding
which approach is more appropriate in a particular situation.
The comparison of the integration patterns, and in particular
CIS, in different clinical gene therapy studies necessitates an
adjustment for different numbers of IS. We present two different
methods of adjustment: a formula-based approach, which has a
theoretical foundation but is sensitive to assumed values of the
input parameters, and a simulation-based approach which is less
limited in scope and does not have explicit distributional
assumptions, but is somewhat heuristic.
Another challenge closely related to CIS analysis is the
occurrence of coincidences of IS in different cell types. In many
gene therapy studies such coincidences may help to understand
which cell-type was initially transduced and how the differentia-
tion occurs. We have developed methods and computer programs
comparing the observed number of coincidences with the number
to be expected by chance alone, accomodating a certain level of
contamination.
In our lab, the presented programs have been applied to various
experimental samples and proven helpful in assessing potential
vector-induced side-effects.
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